SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Spectral Medical Inc.
EDTXF 0.378+8.7%Jul 22 4:00 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Sultan5/24/2024 7:01:05 PM
   of 474
 
AGM on June 7th.. Only two items on proxy.. Election of Directors and Public Accountants..

However, of note is the new director being appointed.. IMHO, this is meaningful in that the director is not only heavy duty but also note the Baxter connection..

Following is the profile..

Cristiano Franzi

Mr. Cristiano Franzi is a seasoned global healthcare executive and board director with a 30-year track record at leading global Med-Tech companies. As President EMEA for businesses of up to $4 billion in size at Baxter, Medtronic, and Covidien, Mr. Franzi has proven his ability to deliver value by developing 12 compelling visions, identifying new market opportunities, and articulating clear growth strategies while streamlining operations and implementing highly disciplined business models. From 2017 to 2023, Mr. Franzi served as President of Baxter EMEA and as a Member of Baxter’s global Executive Leadership team, where his most recent experience included serving as the interim global lead for the spin-off of the $4.5 billion Renal Care business (“Vantive”). Prior to Baxter, Mr. Franzi served as President, EMEA at Medtronic, and prior to that as President, EMEA at Covidien. Before that, he was the Vice President, International Marketing and Business Development at ev3, a private equity-backed medical device start up, where he played a key role in the international expansion of ev3 from inception to its $156 million IPO in 2005. Additionally, he has served as an industry leader on the Board of MedTech Europe, the industry association in Europe. Mr. Franzi also serves as an expert advisor to leading global private equity firms. Mr. Franzi completed the Advanced Management Program (AMP197) at Harvard Business School, holds an MBA from George Washington University, and a bachelor's degree in business administration from The American University.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext